Theraclion

Theraclion company information, Employees & Contact Information

Explore related pages

Related company profiles:

Theraclion is the French MedTech company behind the Sonovein®, the only non-invasive varicose vein treatment. Robotic-driven, Sonovein® is powered by High Intensity Focused Ultrasound (HIFU). It does not require incisions nor an operating room, leaves no scars, and allows patients a quick return to their daily activities. The CE-marked platform has the potential to replace millions of surgical procedures every year. In the United States, Sonovein® is an investigational device limited to investigational use; it is not available for sale in the U.S. Based in Malakoff (Paris), the Theraclion team is made up of some 30 people, most of them involved in technological and clinical development.

Company Details

Employees
38
Founded
-
Address
244 Avenue Pierre Brossolette, Malakoff,92240,france
Phone
33155489070
Email
co****@****ion.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Malakoff
Looking for a particular Theraclion employee's phone or email?

Theraclion Questions

News

Theraclion Growth Up in S1 2025 - Business Wire

Theraclion Growth Up in S1 2025 Business Wire

Theraclion Announces Treatment of First Patients With New SONOVEIN® ‘SpeedPulse’ Feature Accelerating Treatment - Yahoo Finance

Theraclion Announces Treatment of First Patients With New SONOVEIN® ‘SpeedPulse’ Feature Accelerating Treatment Yahoo Finance

Theraclion: Sonovein® Receives MDR Certification, Strengthening Its Commercial Potential - Business Wire

Theraclion: Sonovein® Receives MDR Certification, Strengthening Its Commercial Potential Business Wire

Theraclion Announces Successful U.S. FDA Pivotal Study With 96.8% Occlusion Rate - Business Wire

Theraclion Announces Successful U.S. FDA Pivotal Study With 96.8% Occlusion Rate Business Wire

Theraclion Reviews Its 2024 Achievements - Business Wire

Theraclion Reviews Its 2024 Achievements Business Wire

Sonovein US FDA pivotal study treatments completed: Theraclion reaches key milestone on schedule - Venous News

Sonovein US FDA pivotal study treatments completed: Theraclion reaches key milestone on schedule Venous News

Theraclion launches new robotics vein platform - BioWorld MedTech

Theraclion launches new robotics vein platform BioWorld MedTech

Theraclion nets €11.8M for its ultrasound treatment for varicose veins - Fierce Biotech

Theraclion nets €11.8M for its ultrasound treatment for varicose veins Fierce Biotech

Top Theraclion Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant